Qatari German Company for Medical Devices (Q.P.S.C.) (QSE:QGMD)

QSE:QGMD Cash Flow Statement

Financials in millions QAR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-68.49	1.34	1.24	1.18	0.88
Depreciation & Amortization	4.53	5.35	5.43	5.41	5.48
Loss (Gain) From Sale of Assets	-	-	-	-	-0.01
Asset Writedown & Restructuring Costs	0.15	-2.11	-	-	-4.39
Other Operating Activities	10.14	1.49	2.32	2.48	2.98
Change in Accounts Receivable	43.65	-17.86	-9.45	-2.48	-12.61
Change in Inventory	8.93	2.85	-0.52	-3.36	-11.16
Change in Accounts Payable	2.15	7.96	2.02	5.12	3.87
Operating Cash Flow	1.06	-0.98	1.05	5.76	-15.95
Operating Cash Flow Growth	-	-	-81.83%	-	-
Capital Expenditures	-0.04	-1.05	-0.25	-0.56	-0.66
Sale of Property, Plant & Equipment	-	-	-	-	0.02
Investing Cash Flow	-0.04	-1.05	-0.25	-0.56	-0.64
Long-Term Debt Issued	-	-	0.37	7.89	20.1
Total Debt Issued	-	-	0.37	7.89	20.1
Short-Term Debt Repaid	-	-	-	-	-0.12
Long-Term Debt Repaid	-0.84	-4.2	-0.01	-10.94	-0.01
Total Debt Repaid	-0.84	-4.2	-0.01	-10.94	-0.13
Net Debt Issued (Repaid)	-0.84	-4.2	0.36	-3.05	19.97
Other Financing Activities	-	-	-	-	-1.3
Financing Cash Flow	-0.84	-4.2	0.36	-3.05	18.67
Net Cash Flow	0.18	-6.23	1.15	2.16	2.07
Free Cash Flow	1.02	-2.03	0.8	5.21	-16.62
Free Cash Flow Growth	-	-	-84.72%	-	-
Free Cash Flow Margin	10.23%	-7.28%	1.87%	12.84%	-67.63%
Free Cash Flow Per Share	0.01	-0.02	0.01	0.04	-0.14
Cash Interest Paid	0.57	1.09	1.35	4.74	1.3
Levered Free Cash Flow	14.87	-4.9	-3.54	1.13	-18.04
Unlevered Free Cash Flow	21.59	-3.21	-1.17	4.09	-16.33
Change in Net Working Capital	-54.72	6.82	7.95	4.49	20.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.